pharmaceutical investing Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike